(R)-3-methoxy-4-(4-methyl-2-oxooxazolidin-3-yl)benzoic acid → (R)-3-{4-[4-(3,5-dimethylpyridin-2-yl)piperazine-1-carbonyl]-2-methoxyphenyl}-4-methyloxazolidin-2-one hydrochloride
Reaction equation
[CH3:1][O:2][C:3]1[CH:4]=[C:5]([CH:9]=[CH:10][C:11]=1[N:12]1[C@H:16]([CH3:17])[CH2:15][O:14][C:13]1=[O:18])[C:6]([OH:8])=O.[ClH:19].[CH3:20][C:21]1[C:22]([N:28]2[CH2:33][CH2:32][NH:31][CH2:30][CH2:29]2)=[N:23][CH:24]=[C:25]([CH3:27])[CH:26]=1>>[ClH:19].[CH3:20][C:21]1[C:22]([N:28]2[CH2:29][CH2:30][N:31]([C:6]([C:5]3[CH:9]=[CH:10][C:11]([N:12]4[C@H:16]([CH3:17])[CH2:15][O:14][C:13]4=[O:18])=[C:3]([O:2][CH3:1])[CH:4]=3)=[O:8])[CH2:32][CH2:33]2)=[N:23][CH:24]=[C:25]([CH3:27])[CH:26]=1Participants
3
Procedure
By reaction and treatment in the same manner as in Example 87 and using (R)-3-methoxy-4-(4-methyl-2-oxooxazolidin-3-yl)benzoic acid (1 g) described in Preparation Example 46 and 1-(3,5-dimethylpyridin-2-yl)piperazine hydrochloride (956 mg) described in Preparation Example 64, the title compound (838 mg) was obtained.
Workup
- customBy reaction and treatment in the same manner as in Example 87
- customdescribed in Preparation Example 64
Sources & evidence
- ORD record
- ord-90a759e1eb1545449132415eaac2e119
- Source dataset
- uspto-grants-2013_01
- Patent number
- US08354401B2
Reaction notes
Loading…